Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Recruiting
Observational Study
Frailty
Sarcopenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- University of California, Los Angeles · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective coh…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients admitted to the Surgical, Cardiothoracic or Neuro ICU
* ICU stay longer than 24 hours
Exclusion Criteria:
* Patients with muscular or mitochondrial diseases affecting muscle quality or mass
* Preexisting paralysis
* Absence of lower limbs
* Ongoing discussions…
Contacts